StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Gilead Sciences (GILD) PT Raised to $86 at Jefferies
October 28, 2022 8:59 AM
Jefferies analyst Michael Yee raised the price target on Gilead Sciences (NASDAQ: GILD) to $86.00 (from $78.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
'Unique Oncology Platform': Gilead (GILD) Earns Two Upgrades After Beat-and-raise Quarter
October 28, 2022 9:19 AM
Gilead Sciences (GILD) PT Raised to $87 at JPMorgan
October 28, 2022 7:58 AM
Gilead Sciences (GILD) PT Raised to $75 at Wells Fargo
October 28, 2022 7:27 AM
Gilead Sciences (GILD) PT Raised to $82 at RBC Capital
October 28, 2022 6:13 AM
UPDATE: Piper Sandler Upgrades Gilead Sciences (GILD) to Overweight
October 28, 2022 5:53 AM
Truist Securities Upgrades Gilead Sciences (GILD) to Buy
October 28, 2022 3:52 AM
After-Hours Movers: Amazon Sinks on Lower Guidance, Pinterest Up on Beat
October 27, 2022 5:51 PM
Gilead Sciences Beat Expectations and Raised its Full-Year Outlook
October 27, 2022 4:26 PM
Form 8-K GILEAD SCIENCES, INC. For: Oct 27
October 27, 2022 4:05 PM
Gilead Sciences (GILD) Tops Q3 EPS by 38c
October 27, 2022 4:01 PM
Gilead Sciences Announces Third Quarter 2022 Financial Results
October 27, 2022 4:01 PM
